News & Events

  • January 21, 2015

    Client Alert: New York Repeals WTPA’s Annual Wage Notice requirement and minimum wage raises To $8.75 per hour for non-exempt workers and $656.25 per week for exempt workers.  Click here for more details.

  • October 22, 2014

    Orlando Bathing Suit LLC, a national retailer of swimsuits under the trade name Everything But Water, acquired Aqua Beachwear, a Florida based swimsuit retailer. EG&S acted as counsel to Orlando Bathing Suit in this transaction.

  • October 14, 2014

    International Stem Cell Corporation announced the closing of their PIPE offering in the amount of $2,500,000.  EG&S acted as counsel to the Placement Agent.

  • October 10, 2014

    Ellenoff Grossman & Schole LLP was ranked #1 for placement agent representation in PIPE transactions (by number of transactions) for Q3 2014.

    Click here to view the rankings

  • October 10, 2014

    Cytori Therapeutics, Inc. announced the closing of their Registered Direct offering in the amount of $13,500,000.  EG&S acted as counsel to the Investor.

  • October 06, 2014

    DT Asia Investments Limited announced the completion of their IPO in the amount of $60,000,000.  EG&S acted as counsel to DT Asia.

  • September 29, 2014

    Lpath, Inc. announced the closing of its previously announced $12.5 million registered direct offering. Lpath sold registered shares of common stock and warrants to purchase unregistered shares of common stock in a registered direct offering. EG&S acted as counsel to the placement agent.

  • September 24, 2014

    Baxano Surgical, Inc. announced the closing of their Registered Direct offering in the amount of $1,384,801.  EG&S acted as counsel to the Investor.

  • September 23, 2014

    Advanced Plasma Therapies, Inc., a privately held, development-stage biotechnology company, closed a private common stock financing of $25 million with a single institutional investor. EG&S acted as counsel to Advanced Plasma Therapies.

  • September 23, 2014

    LabStyle Innovations Corp. (OTCQB:DRIO) announced the closing of a $4.2 million private placement consisting of preferred stock and warrants. EG&S acted as counsel to LabStyle. 

  • September 22, 2014

    Hennessy Capital Acquisition Corp. announced the agreement to acquire Blue Bird. EG&S acted as co-counsel to Hennessy with Sidley Austin LLP.

  • September 11, 2014

    Douglas S. Ellenoff, a member of the Firm, will receive the "Crowdfunding Visionary Award" at the 3rd Annual Global Crowdfunding Convention and Bootcamp this October in Las Vegas.

    Click here for more details

  • September 11, 2014

    Client Alert: Issuers and Corporate Insiders Should Revisit Procedures for Reporting Ownership in View of SEC’s Announcement of Enforcement Proceedings.  The alert prepared by Adrienne Ward and David Selengut, members of the Firm, discusses this new enforcement initiative and suggest best practices for issuers and corporate officers.

    Click here to read the alert

  • September 03, 2014

    Orient Paper Inc. announced the closing of their Registered Direct offering in the amount of $2,500,000.  EG&S acted as counsel to the Placement Agent.

  • August 29, 2014

    Integrity Applications, Inc. announced the closing of their private placement in the amount of $3,000,000.  EG&S acted as counsel to the placement agent.

  • August 27, 2014

    High Performance Beverages Company announced the closing of their Registered Direct offering in the amount of $160,000.  EG&S acted as counsel to the Investor.

  • August 27, 2014

    Wafergen Bio-Systems Inc. announced the closing of their Underwritten offering in the amount of $20,000,006.  EG&S acted as counsel to the Underwriter.

  • August 26, 2014

    Px/Radia, Inc. announced the closing of their Registered Direct offering in the amount of $500,000.  EG&S acted as counsel to the Investor.

  • August 20, 2014

    Cellectar Biosciences Inc. announced the closing of their Underwritten offering in the amount of $12,935,965.  EG&S acted as counsel to the Underwriter.

  • August 20, 2014

    Cellectar Biosciences, Inc. announced the closing of their underwritten offering in the amount of  $16,000,000.  EG&S acted as counsel to the underwriter, Aegis Capital Corp.

  • August 14, 2014

    TapImmune Inc. announced the closing of their Registered Direct offering in the amount of $1,999,999.  EG&S acted as counsel to the Placement Agent.

  • August 12, 2014

    Richard I. Anslow, a member of the Firm, will participate in the Uplisting Bootcamp Conference in Los Angeles on September 19, 2014.  Click here for more details.

  • August 11, 2014

    Jennifer Silverman, a member of the Firm, will be leading a trademark administrator Roundtable discussion on Friday, September 5th entitled: “The Office Action: A Challenge or a Cinch?” The Roundtable will take place from 12:00 to 2:00 pm at EG&S’ offices and lunch will be served. For more information and registration, click here.

  • August 11, 2014

    Richard I. Anslow, a member of the Firm, will participate in this year's Rodman & Renshaw Global Investment Conference.  Mr. Anslow is one of the panelists on the Uplisting Bootcamp Panel on September 9th at 12:30pm.   Click here for more details.

  • August 05, 2014

    Herman Miller, Inc. (NASDAQ: MLHR) announced the acquisition of Design Within Reach, Inc. (OTC: DWRI).  Herman Miller and its affiliates initially acquired an ownership interest of over 96% in Design Within Reach (DWR) pursuant to a stock purchase agreement with the principal shareholders of DWR and a contribution and rollover agreement with certain shareholders of DWR, and then did a short-form merger to cash out the remaining DWR shareholders at the same price paid to DWR shareholders under the stock purchase agreement.  EG&S acted as counsel to DWR.